140 related articles for article (PubMed ID: 25277531)
41. The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma.
Fan Y; Zhang X; Yang ZH; Sun XW; Li SN; Zhong L; Cheng X; Wang Y; Ma YR
DNA Cell Biol; 2013 Oct; 32(10):594-600. PubMed ID: 23952692
[TBL] [Abstract][Full Text] [Related]
42. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
[TBL] [Abstract][Full Text] [Related]
43. Association of an Osteopontin gene promoter polymorphism with susceptibility to diabetic nephropathy in Asian Indians.
Cheema BS; Iyengar S; Ahluwalia TS; Kohli HS; Sharma R; Shah VN; Bhansali A; Sakhuja V; Khullar M
Clin Chim Acta; 2012 Oct; 413(19-20):1600-4. PubMed ID: 22584029
[TBL] [Abstract][Full Text] [Related]
44. The effects of gene polymorphisms on glioma prognosis.
Cui Y; Li G; Yan M; Li J; Jin T; Li S; Mu S
J Gene Med; 2017 Nov; 19(11):345-352. PubMed ID: 28985021
[TBL] [Abstract][Full Text] [Related]
45. Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.
Wang JL; Nong LG; Tang YJ; Wei YS; Yang FL; Wang CF
Med Oncol; 2014 Jul; 31(7):20. PubMed ID: 24913806
[TBL] [Abstract][Full Text] [Related]
46. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract][Full Text] [Related]
47. Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population.
Li W; Qian C; Wang L; Teng H; Zhang L
Tumour Biol; 2014 Mar; 35(3):2259-64. PubMed ID: 24287948
[TBL] [Abstract][Full Text] [Related]
48. TERT rs2853676 polymorphisms correlate with glioma prognosis in Chinese population.
He X; Wei Y; Chen Z; Zhu X; Ma L; Zhang N; Zhang Y; Kang L; Yuan D; Zhang Z; Jin T
Oncotarget; 2016 Nov; 7(45):73781-73791. PubMed ID: 27655710
[TBL] [Abstract][Full Text] [Related]
49. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
Lee YH; Song GG
Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
[TBL] [Abstract][Full Text] [Related]
50. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
51. Association of Osteopontin gene single nucleotide polymorphism with lupus nephritis.
Metwally RM; Hasan AS; R EG
Int J Rheum Dis; 2022 May; 25(5):571-575. PubMed ID: 35218609
[TBL] [Abstract][Full Text] [Related]
52. CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.
Chang SF; Li SL; Yang B; Yao KM; Miao RH; Liang GF; Zhang KM
Genet Mol Res; 2015 Dec; 14(4):17399-405. PubMed ID: 26782381
[TBL] [Abstract][Full Text] [Related]
53. Association between genetic polymorphisms of PTGS2 and glioma in a Chinese population.
Lin RP; Yao CY; Ren DX
Genet Mol Res; 2015 Apr; 14(2):3142-8. PubMed ID: 25966079
[TBL] [Abstract][Full Text] [Related]
54. MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: the association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib.
Liu YC; Hsiao HH; Yang WC; Liu TC; Chang CS; Yang MY; Lin PM; Hsu JF; Lee CP; Lin SF
Mol Carcinog; 2014 Dec; 53(12):951-9. PubMed ID: 23818300
[TBL] [Abstract][Full Text] [Related]
55. Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.
Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
Med Oncol; 2014 Dec; 31(12):301. PubMed ID: 25367853
[TBL] [Abstract][Full Text] [Related]
56. Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.
Zhang J; Yang J; Chen Y; Mao Q; Li S; Xiong W; Lin Y; Chen J; Ge J
Mol Neurobiol; 2016 May; 53(4):2610-8. PubMed ID: 26093379
[TBL] [Abstract][Full Text] [Related]
57. Role of PVT1 polymorphisms in the glioma susceptibility and prognosis.
Ding X; Zhao Y; Yuan H; Zhang Y; Gao Y
Eur J Cancer Prev; 2021 Sep; 30(5):400-408. PubMed ID: 33443959
[TBL] [Abstract][Full Text] [Related]
58. Investigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population.
Fan SC; Zhou JG; Yin JZ
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706616
[TBL] [Abstract][Full Text] [Related]
59. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
60. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
